Drugs by condition
Drugs approved for allergies (allergic rhinitis)
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
18
Still marketed, NDA or BLA
Drug classes
3
Novel drugs
5
New molecular entities and new biologics
In development
16
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for allergies (allergic rhinitis).
- Ryaltris (Mometasone Furoate, Olopatadine Hydrochloride) · Glenmark Speclt Jan 13, 2022
- Karbinal Er (Carbinoxamine Maleate) · Aytu Mar 28, 2013
- Dymista (Azelastine Hydrochloride, Fluticasone Propionate) · Mylan Speciality Lp May 1, 2012
- Qnasl (Beclomethasone Dipropionate) · Teva Branded Pharm OrphanMar 23, 2012
- Omnaris (Ciclesonide) · Azurity NovelOct 20, 2006
All approved drugs for allergies (allergic rhinitis), by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 223 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Corticosteroid (3)
- Medrol Methylprednisolone · Pfizer · 1957
- Kenalog-40 Triamcinolone Acetonide · Apothecon · 1965
- Cortef Hydrocortisone · Pharmacia and Upjohn · 1952
Histamine-1 Receptor Antagonist (2)
- Clarinex Desloratadine · Organon · 2001
- Clarinex-D 12 Hour Desloratadine, Pseudoephedrine Sulfate · Organon LLC · 2006
Class not listed in FDA's data (13)
- Omnaris Ciclesonide · Azurity · 2006
- Singulair Montelukast Sodium · Organon · 1998
- Celestone Soluspan Betamethasone Acetate, Betamethasone Sodium Phosphate · Organon · 1965
- Ryaltris Mometasone Furoate, Olopatadine Hydrochloride · Glenmark Speclt · 2022
- Karbinal Er Carbinoxamine Maleate · Aytu · 2013
- Dymista Azelastine Hydrochloride, Fluticasone Propionate · Mylan Speciality Lp · 2012
- Qnasl Beclomethasone Dipropionate · Teva Branded Pharm · 2012
- Orapred Odt Prednisolone Sodium Phosphate · Advanz Pharma · 2006
- Singulair Montelukast Sodium · Organon · 1998
- Pediapred Prednisolone Sodium Phosphate · Pai Holdings · 1986
- Depo-Medrol Methylprednisolone Acetate · Pfizer · 1959
- Solu-Medrol Methylprednisolone Sodium Succinate · Pharmacia and Upjohn · 1959
- Solu-Cortef Hydrocortisone Sodium Succinate · Pharmacia and Upjohn · 1955
Drugs in development for allergies (allergic rhinitis)
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- CM512Phase 39 trials
Keymed Biosciences Co.Ltd · Chronic Rhinosinusitis With Nasal Polyposis, Chronic Spontaneous Urticaria (CSU), Asthma
- LP-003SinglePhase 39 trials
Longbio Pharma · Allergic Asthma, Chronic Spontaneous Urticaria (CSU), Peanut Allergies
- SHR-1819Phase 38 trials
Guangdong Hengrui Pharmaceutical Co., Ltd · Seasonal Allergic Rhinitis, Moderate to Severe Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis
- JYB1904RPT904, ozureprubartPhase 35 trials
Jemincare · Chronic Spontaneous Urticaria, Perennial Allergic Rhinitis, Immune System Diseases
- GR1802Phase 34 trials
Genrix (Shanghai) Biopharmaceutical Co., Ltd. · Allergic Rhinitis, Seasonal, Allergic Rhinitis, Chronic Rhinosinusitis With Nasal Polyps
- MG-K10 Humanized Monoclonal AntibodyPhase 34 trials
Shanghai Mabgeek Biotech.Co.Ltd · Atopic Dermatitis, Seasonal Allergic Rhinitis, Chronic Spontaneous Urticaria (CSU)
- StapokibartPhase 34 trials
Chengdu Kangnuoxing Biopharma,Inc. · Seasonal Allergic Rhinitis (SAR), Bullous Pemphigoid (BP), Prurigo Nodularis
- TQH2722Phase 33 trials
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · Seasonal Allergic Rhinitis, Atopic Dermatitis
- 000 MM09Phase 32 trials
Inmunotek S.L. · Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic
- DEP114Phase 32 trials
EMS · Persistent Allergic Rhinitis, Allergic Rhinitis
- EP-088_MM09Phase 32 trials
Inmunotek S.L. · Allergic Rhinitis, Allergic Rhinoconjunctivitis, Allergic Asthma
- AK139Phase 26 trials
Akeso · Asthma, Moderate-to-Severe Atopic Dermatitis, Chronic Spontaneous Urticaria
- TQC2938Phase 22 trials
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Chronic Obstructive Pulmonary Disease, Seasonal Allergic Rhinitis
- ALDP001Phase 21 trial
Alixer Nexgen Therapeutics Limited · Seasonal Allergic Rhinitis (SAR)
- INI-2004Phase 21 trial
Inimmune Corporation · Allergic Rhinitis Due to Allergens, Rhinitis Allergic, Allergic Rhinitis
- JT002Phase 21 trial
Shanghai JunTop Biosciences Co., LTD · Seasonal Allergic Rhinitis
3 discontinued brand-name drugs whose label still names it
More on allergies (allergic rhinitis): recruiting trials · published research
Related in respiratory: Pulmonary arterial hypertension · Asthma · COPD · Cystic fibrosis · Idiopathic pulmonary fibrosis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.